Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$494.46 USD
-11.32 (-2.24%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $494.52 +0.06 (0.01%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $3.98 | -2.62% |
Earnings Summary
For their last quarter, Vertex Pharmaceuticals (VRTX) reported earnings of -$12.83 per share, missing the Zacks Consensus Estimate of -$11.50 per share. This reflects a negative earnings surprise of 11.57%. Look out for VRTX's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of $3.98 per share, reflecting a year-over-year decrease of 2.45%.
Earnings History
Price & Consensus
Zacks News for VRTX
Vertex (VRTX) Q2 Loss Wider Than Expected, '24 Sales View Raised
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services